Apr 22, 2024
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Mar 26, 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Mar 19, 2024
Endo Announces Confirmation of Plan of Reorganization
Feb 29, 2024
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
Jan 24, 2024
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
Jan 22, 2024
Endo's Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Jan 19, 2024
Endo Announces New Data for Dupuytren's Contracture Presented at the American Association for Hand Surgery Annual Meeting
Feb 17, 2021
Endo Appoints Jennifer M. Chao to Board of Directors
Jan 26, 2021
Endo to Announce Fourth-Quarter and Full-Year 2020 Financial Results
Jan 05, 2021
Endo Announces Licensing Agreement for Paladin Labs Inc. to Commercialize Abaloparatide in Canada
Jan 05, 2021
Endo Aesthetics Launches "Really Cellulite" Campaign
Jan 04, 2021
Endo Launches Authorized Generic Version of Amitiza® (lubiprostone) Capsules in the United States
Dec 18, 2020
Endo to Participate at J.P. Morgan 39th Annual Healthcare Conference
Nov 05, 2020
Endo Reports Third-Quarter 2020 Financial Results And Raises Full Year 2020 Financial Guidance
Nov 05, 2020
Endo Announces Strategic Actions to Further Position the Company for Long-Term Success
Nov 02, 2020
Endo International plc Commences Tender Offer for All Outstanding Shares of BioSpecifics Technologies Corp.
Oct 19, 2020
Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo(TM)
Oct 09, 2020
Endo Aesthetics Data to be Featured in Five Presentations at the American Society for Dermatologic Surgery's Annual Meeting (ASDS)
Oct 07, 2020
Endo to Announce Third Quarter 2020 Financial Results
Oct 06, 2020
Endo Releases First Environmental, Social and Governance Report